Live Breaking News & Updates on Navidea Biopharmaceuticals Inc

Stay updated with breaking news from Navidea biopharmaceuticals inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Navidea Biopharmaceuticals (NYSE:NAVB) Receives New Coverage from Analysts at StockNews.com

StockNews.com started coverage on shares of Navidea Biopharmaceuticals (NYSE:NAVB – Free Report) in a research note issued to investors on Thursday morning. The firm issued a sell rating on the stock. Navidea Biopharmaceuticals Trading Down 99.7 % NYSE NAVB opened at $0.00 on Thursday. The company has a 50 day moving average of $0.04 and […] ....

Navidea Biopharmaceuticals Inc , Therapeutic Development Programs , Navidea Biopharmaceuticals , Free Report , Biopharmaceuticals Trading Down , Get Free Report , Diagnostic Substances , Therapeutic Development , Navidea Biopharmaceuticals Daily ,

Navidea Biopharmaceuticals (NYSE:NAVB) Research Coverage Started at StockNews.com

StockNews.com assumed coverage on shares of Navidea Biopharmaceuticals (NYSE:NAVB – Free Report) in a research note issued to investors on Thursday. The brokerage issued a sell rating on the stock. Navidea Biopharmaceuticals Stock Performance Shares of NAVB opened at $0.00 on Thursday. Navidea Biopharmaceuticals has a fifty-two week low of $0.00 and a fifty-two week […] ....

Navidea Biopharmaceuticals Inc , Therapeutic Development Programs , Navidea Biopharmaceuticals , Free Report , Get Free Report , Diagnostic Substances , Therapeutic Development , Navidea Biopharmaceuticals Daily ,

Navidea Biopharmaceuticals (NYSE:NAVB) Research Coverage Started at StockNews.com

StockNews.com initiated coverage on shares of Navidea Biopharmaceuticals (NYSE:NAVB – Free Report) in a research note released on Thursday. The brokerage issued a sell rating on the stock. Navidea Biopharmaceuticals Stock Performance Navidea Biopharmaceuticals has a twelve month low of $0.00 and a twelve month high of $0.17. The stock’s fifty day moving average price […] ....

Therapeutic Development Programs , Navidea Biopharmaceuticals Inc , Navidea Biopharmaceuticals , Free Report , Get Free Report , Diagnostic Substances , Therapeutic Development , Navidea Biopharmaceuticals Daily ,

Navidea Biopharmaceuticals (NYSE:NAVB) Coverage Initiated at StockNews.com

Navidea Biopharmaceuticals (NYSE:NAVB) Coverage Initiated at StockNews.com
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Therapeutic Development Programs , Navidea Biopharmaceuticals Company Profile , Navidea Biopharmaceuticals Inc , Navidea Biopharmaceuticals , Get Free Report , Diagnostic Substances , Therapeutic Development , Navidea Biopharmaceuticals Daily ,

Navidea Biopharmaceuticals (NYSE:NAVB) Coverage Initiated by Analysts at StockNews.com

StockNews.com started coverage on shares of Navidea Biopharmaceuticals (NYSE:NAVB – Free Report) in a research note released on Monday morning. The firm issued a sell rating on the stock. Navidea Biopharmaceuticals Stock Performance Shares of NAVB opened at $0.04 on Monday. The company has a 50-day simple moving average of $0.04 and a 200-day simple […] ....

Therapeutic Development Programs , Navidea Biopharmaceuticals Inc , Navidea Biopharmaceuticals Company Profile , Navidea Biopharmaceuticals , Free Report , Get Free Report , Diagnostic Substances , Therapeutic Development , Navidea Biopharmaceuticals Daily , Nyse Navb , Initiated Coverage , Stocknews Com ,